Using Medicaid data to advance care for people with schizophrenia at risk for HIV (Medicaid-DASH)
Using Medicaid data to advance care for people with schizophrenia at risk for HIV (Medicaid-DASH)
批准号:
9903937
负责人:
Christina Mangurian
金额:
$24.98万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2023-03-31
关键词:
AddressAgeAreaAwardBipolar DisorderCaringCategoriesCommunicable DiseasesContinuity of Patient CareDataData SetDevelopmentDiagnosisDimensionsEpidemicEpidemiologic MethodsEthnic OriginFoundationsFrequenciesFundingGeneral PopulationGeographyGoalsHIVHealthHeterogeneityHuman immunodeficiency virus testIndividualInequalityInterventionKnowledgeMedicaidMentored Research Scientist Development AwardMentorsMethodologyMethodsOutcomeParentsPatient Self-ReportPopulationPositioning AttributeRaceRecording of previous eventsResearchResearch MethodologyResearch PersonnelRetrospective cohortRiskSample SizeSchizophreniaSocial HierarchySocial IdentificationStatistical MethodsTestingTimeTrainingUnited StatesUnited States National Institutes of HealthVulnerable PopulationsWorkadministrative databaseblack mencare outcomescareercareer developmentcohortcost effective interventionexperiencehealth disparityhealth inequalitiesimprovedimproved outcomeintersectionalityintravenous drug uselensmarginalized populationmemberparent grantpublic health interventionsevere mental illnesssexskillssocialsocial determinantssocial epidemiologysocial exclusiontransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
People with severe mental illness (e.g., schizophrenia, bipolar disorder; SMI) are a socially marginalized
population with up to ten times increased likelihood of being diagnosed with HIV compared to the general
United States population. The parent grant (R01-MH112420) aims to investigate the increased HIV
transmission risk, low testing rate, and potential HIV treatment gaps for people with SMI using a large,
geographically diverse national retrospective longitudinal Medicaid cohort. The outcomes assessed by the
parent grant, however, may be modified by membership in intersecting categories of social marginalization.
Single-axis interventions that do not consider heterogeneities among vulnerable populations may not be
effective in improving outcomes and achieving epidemic control. Therefore, research is needed to identify and
assess the magnitude of outcome inequalities among the riskiest intersectional positions.
Leveraging twelve years of Medicaid data (2001 through 2012), the major goal of this research is to assess the
existence and magnitude of outcome inequalities along the HIV continuum of care, with respect to intersecting
categories of social marginalization (e.g. schizophrenia diagnosis, race/ethnicity, sex, intravenous drug use,
etc.). The diversity supplement seeks to provide mentored theoretical and methodological training for the
candidate in the area of quantitative intersectionality research. The proposed career development aims are: (1)
to develop foundational knowledge in intersectionality as a theoretical framework; and (2) to develop expertise
in quantitative intersectionality research methods. Aligned with the career development objectives, the
research goals of the proposed study are to: (a) research the cutting-edge quantitative intersectionality
approaches to assess the existence and magnitude of HIV outcome inequalities within a large administrative
database; (b) examine differential rates of HIV testing by intersecting categories of schizophrenia diagnosis,
sex, age, history of intravenous drug use, and race/ethnicity in the R01 parent grant retrospective cohort; and
(c) examine differential rates of treatment for HIV by intersecting categories of schizophrenia diagnosis, sex ,
age, history of intravenous drug use, and race/ethnicity in the R01 parent grant retrospective cohort. The
evidence generated from this work could identify the riskiest intersectional positions to inform targeted, cost-
effective, interventions to improve HIV testing and care outcomes among those most vulnerable. Additionally,
the foundational knowledge of intersectionality as a theoretical framework, paired with the application of
quantitative intersectionality methods to a large administrative data set, will position the candidate to have an
impactful career as an independent investigator generating rigorous quantitative evidence demonstrating
health inequities among socially marginalized populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using Medicaid data to advance care for people with schizophrenia at risk for HIV (Medicaid-DASH)
-
批准号:9899823
-
项目类别:
-
资助金额:$65.65万
-
财政年份:2017
-
负责人:Christina Mangurian
-
依托单位:
Improving Metabolic Screening in Diverse Severely Mentally Ill Populations
-
批准号:9119047
-
项目类别:
-
资助金额:$17.77万
-
财政年份:2012
-
负责人:Christina Mangurian
-
依托单位:
Improving Metabolic Screening in Diverse Severely Mentally Ill Populations
-
批准号:8532042
-
项目类别:
-
资助金额:$17.77万
-
财政年份:2012
-
负责人:Christina Mangurian
-
依托单位:
Improving Metabolic Screening in Diverse Severely Mentally Ill Populations
-
批准号:8241654
-
项目类别:
-
资助金额:$17.77万
-
财政年份:2012
-
负责人:Christina Mangurian
-
依托单位:
Improving Metabolic Screening in Diverse Severely Mentally Ill Populations
-
批准号:8703791
-
项目类别:
-
资助金额:$17.77万
-
财政年份:2012
-
负责人:Christina Mangurian
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: